Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158, USA.
Gladstone Institute of Cardiovascular Disease, San Francisco, California 94143, USA.
Nat Commun. 2016 Jul 1;7:12009. doi: 10.1038/ncomms12009.
Cas9-based RNA-guided nuclease (RGN) has emerged to be a versatile method for genome editing due to the ease of construction of RGN reagents to target specific genomic sequences. The ability to control the activity of Cas9 with a high temporal resolution will facilitate tight regulation of genome editing processes for studying the dynamics of transcriptional regulation or epigenetic modifications in complex biological systems. Here we show that fusing ligand-binding domains of nuclear receptors to split Cas9 protein fragments can provide chemical control over split Cas9 activity. The method has allowed us to control Cas9 activity in a tunable manner with no significant background, which has been challenging for other inducible Cas9 constructs. We anticipate that our design will provide opportunities through the use of different ligand-binding domains to enable multiplexed genome regulation of endogenous genes in distinct loci through simultaneous chemical regulation of orthogonal Cas9 variants.
基于 Cas9 的 RNA 引导的核酸酶(RGN)由于易于构建针对特定基因组序列的 RGN 试剂而成为一种通用的基因组编辑方法。通过高时间分辨率控制 Cas9 的活性将有助于对基因组编辑过程进行严格调控,以便在复杂的生物系统中研究转录调控或表观遗传修饰的动态。在这里,我们展示了将核受体的配体结合结构域融合到分裂 Cas9 蛋白片段中,可以提供对分裂 Cas9 活性的化学控制。该方法使我们能够以无明显背景的方式以可调的方式控制 Cas9 的活性,这对于其他诱导型 Cas9 构建体来说是具有挑战性的。我们预计,我们的设计将通过使用不同的配体结合结构域,为通过同时化学调控正交 Cas9 变体来对不同基因座的内源性基因进行多路基因组调控提供机会。